Verastem | VSTM - Bienes





Bienes Cambio Fecha
AbbVie USD 136.46B 2.5B 2026-03
Alaunos Therapeutics USD 2.97M 758K 2025-12
AstraZeneca USD 114.02B 59M 2026-03
Curis USD 19.97M 9.27M 2025-12
Cytokinetics USD 1.27B 151.06M 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
Incyte USD 7.34B 381.14M 2026-03
Laboratory Of America USD 19.09B 694.4M 2026-03
Novartis USD 118.53B 7.58B 2026-03
Pfizer USD 207.62B 542M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
TG Therapeutics USD 1.53B 465.58M 2026-03
Verastem USD 246.44M 69.59M 2025-12